Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2591 of 6351
-
Can an unapproved device change patient care? a trial puts it to the test
Disease control Details not publishedSponsor: [Redacted] • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope: early access to investigational drug for solid tumors
Disease control Expanded accessThis is an expanded access program (EAP) for eligible participants. This program is designed to provide access to telisotuzumab adizutecan prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for ROS1+ cancer patients: expanded access to zidesamtinib
Disease control Expanded accessThe Expanded Access Program will provide an alternate mechanism for these patients, who lack satisfactory therapeutic alternatives and cannot participate in a zidesamtinib clinical trial, to access investigational zidesamtinib. Following FDA Approval of zidesamtinib on 22 July 20…
Sponsor: Nuvalent Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hope: expanded access to cemiplimab for cancer patients
Disease control ApprovedProvide expanded access of cemiplimab in patients with solid tumors
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Last-Resort drug alpelisib made available for patients with no other options
Disease control Expanded accessThe purpose of this registration is to list Managed Access Programs (MAPs) related to BYL719, Alpelisib
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Last-Resort drug access: asciminib opens for CML patients
Disease control Expanded accessThe purpose of this registration form is to list all Managed Access Programs (MAPs) related to ABL001, asciminib
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for kidney disease patients: managed access to EXV811, atrasentan
Disease control Expanded accessThe purpose of this registration is to list Managed Access Programs (MAPs) related to EXV811, Atrasentan
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug ABBV-706 made available for some lung cancer patients before approval
Disease control Expanded accessThis is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-706 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benef…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Poop pills fight superbug infections!
Disease control Expanded accessThe Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 is prepared from human stool from a healthy, screened donor. Requestors will contact the study team about the product (PRIM-DJ2727) by email, visit, or phone call. A screening list for donors will be provided to make…
Sponsor: Herbert DuPont, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Early access program offers investigational meningioma treatment
Disease control Expanded accessThis Expanded Access Program (EAP) is intended to provide eligible participants with access to ITM-11 prior to approval by local regulatory authorities. Program availability is subject to country eligibility. The treating physician must determine, based on the individual patient´…
Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Hope for MSA patients: continued access to experimental drug ATH434
Disease control Expanded accessThis multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.
Sponsor: Alterity Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental device aims to tame disease
Disease control Details not publishedSponsor: [Redacted] • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a new device change disease management?
Disease control Details not publishedSponsor: [Redacted] • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for mastocytosis patients: expanded access to bezuclastinib
Disease control Expanded accessThe purpose of this expanded access program (EAP) protocol is to provide investigational bezuclastinib to patients with a diagnosis of nonadvanced systemic mastocytosis (NonAdvSM) or advanced systemic mastocytosis (AdvSM) who have received and failed or been intolerant to at leas…
Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New scan spots tiny pancreatic tumors that cause dangerous low blood sugar
Diagnosis Expanded accessThis purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedema…
Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Desperate patients get early access to promising new drug
Disease control Expanded accessProvide pre-approval single-patient expanded access of retatrutide (LY3437943), an investigational GLP-1/GIP/glucagon triple receptor agonist being studied for chronic weight management, for adults with severe obesity (body mass index \[BMI\] greater than or equal to \[≥\]35 kilo…
Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental device aims to tame disease
Disease control Details not publishedSponsor: [Redacted] • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Ultra-Fast radiation zaps skin cancer in new pilot trial
Disease control Not yet recruitingThe primary purpose of this research trial is to study the safety of electron FLASH treatment for cutaneous lymphoma lesions. In addition, investigators will confirm the accuracy of dose and dose rate delivery of electron FLASH therapy using on-patient dosimetry measurements in c…
Sponsor: Lesley A. Jarvis • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
AI and community health workers team up to help diabetes patients after hospital stays
Disease control Not yet recruitingThis study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications d…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Weeding out stress: gardening program aims to boost cancer Survivors' Well-Being
Symptom relief Not yet recruitingThis study is testing whether a gardening and nutrition program can improve well-being in people who have had cancer. Many cancer survivors continue to experience challenges after treatment, including changes in appetite, nutrition, stress, and quality of life. Programs that comb…
Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC